Aspen API. More than just an API™
01 1Aspen Oss B.V.
02 1Bayer AG
03 1STERLING SPA
04 2Valdepharm
01 1NORETHINDRONE ACETATE
02 1Norethindrone Acetate
03 1Norethindrone acetate
04 1Norethindrone acetate micronized
05 1Norethisterone acetate
01 1Germany
02 1Italy
03 2Luxembourg
04 1Netherlands
Aspen API. More than just an API™
NDC Package Code : 60870-0236
Start Marketing Date : 1980-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12866-1014
Start Marketing Date : 2017-05-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24823-908
Start Marketing Date : 2010-05-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24823-909
Start Marketing Date : 2011-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64918-1404
Start Marketing Date : 2014-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
89
PharmaCompass offers a list of Norethisterone Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Norethisterone Acetate manufacturer or Norethisterone Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Norethisterone Acetate manufacturer or Norethisterone Acetate supplier.
PharmaCompass also assists you with knowing the Norethisterone Acetate API Price utilized in the formulation of products. Norethisterone Acetate API Price is not always fixed or binding as the Norethisterone Acetate Price is obtained through a variety of data sources. The Norethisterone Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A GILDESS 1/20-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GILDESS 1/20-1, including repackagers and relabelers. The FDA regulates GILDESS 1/20-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GILDESS 1/20-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of GILDESS 1/20-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A GILDESS 1/20-1 supplier is an individual or a company that provides GILDESS 1/20-1 active pharmaceutical ingredient (API) or GILDESS 1/20-1 finished formulations upon request. The GILDESS 1/20-1 suppliers may include GILDESS 1/20-1 API manufacturers, exporters, distributors and traders.
click here to find a list of GILDESS 1/20-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing GILDESS 1/20-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for GILDESS 1/20-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture GILDESS 1/20-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain GILDESS 1/20-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a GILDESS 1/20-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of GILDESS 1/20-1 suppliers with NDC on PharmaCompass.
We have 4 companies offering GILDESS 1/20-1
Get in contact with the supplier of your choice:
